Abliva Ab 주식 가격. 0QDU - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

가격

2.65

매수가

0.00

매도가

0.00

거래량

0.00

0.00 일간 변동폭 0.00

2.65 52주 범위 2.65

market_cap

2.799B

전일 종가

2.65

개장가

최근 거래 시간

(O)

마지막 거래 시간

재정 규모

VWAP

평균 볼륨(3m)

12,697

발행 주식

1,056,299,000

배당수익률

주가수익률

-29.31

주당순이익(EPS)

-0.09

매출

137k

순이익

-95.51M

섹터

Med, Dental, Hosp Eq-whsl

산업

Med, Dental, Hosp Eq-whsl

웹사이트

www.abliva.com

본부

Lund, Swe

설립됨

Abliva Ab is listed in the Med, Dental, Hosp Eq-whsl sector of the 런던증권거래소 with ticker 0QDU. The last closing price for Abliva Ab was SEK2.65. Over the last year, Abliva Ab shares have traded in a share price range of SEK 2.65 to SEK 2.65.

Abliva Ab currently has 1,056,299,000 shares in issue. The market capitalisation of Abliva Ab is SEK2.80 billion. Abliva Ab has a price to earnings ratio (PE ratio) of -29.31.

NeuroVive Pharmaceutical AB Year End Report January - December 2019

NeuroVive Pharmaceutical AB Year End Report January - December 2019 PR Newswire STOCKHOLM, Feb. 19, 2020 STOCKHOLM, Feb. 19, 2020 /PRNewswire/...

NeuroVive Pharmaceutical AB Year End Report January - December 2019

NeuroVive Pharmaceutical AB Year End Report January - December 2019 PR Newswire STOCKHOLM, Feb. 19, 2020 STOCKHOLM, Feb. 19, 2020 /PRNewswire/...

NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study

NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study PR Newswire LUND, Sweden, Dec. 20, 2019 LUND...

NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study

NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study PR Newswire LUND, Sweden, Dec. 20, 2019 LUND...

NeuroVive Announces Settlement in Dispute With CicloMulsion AG

NeuroVive Announces Settlement in Dispute With CicloMulsion AG PR Newswire LUND, Sweden, Dec. 16, 2019 LUND, Sweden, Dec. 16, 2019 /PRNewswire/...

NeuroVive Announces Settlement in Dispute With CicloMulsion AG

NeuroVive Announces Settlement in Dispute With CicloMulsion AG PR Newswire LUND, Sweden, Dec. 16, 2019 LUND, Sweden, Dec. 16, 2019 /PRNewswire/...

NeuroVive Pharmaceutical AB Interim Report January - September 2019

NeuroVive Pharmaceutical AB Interim Report January - September 2019 PR Newswire STOCKHOLM, Nov. 20, 2019 - Continued Progress in KL1333...

NeuroVive Pharmaceutical AB Interim Report January - September 2019

NeuroVive Pharmaceutical AB Interim Report January - September 2019 Continued Progress in KL1333 PR Newswire STOCKHOLM, Nov. 20, 2019 STOCKHOLM...

NeuroVive Pharmaceutical AB Interim Report January - June 2019

NeuroVive Pharmaceutical AB Interim Report January - June 2019 PR Newswire STOCKHOLM, Aug. 21, 2019 Focus on genetic mitochondrial diseases...

NeuroVive Pharmaceutical AB Interim Report January - June 2019

NeuroVive Pharmaceutical AB Interim Report January - June 2019 Focus on genetic mitochondrial diseases PR Newswire STOCKHOLM, Aug. 21, 2019...

기간	시가	고가	저가	평균 일일 거래량	VWAP
1	2.65	2.65	2.65	0	0	DE
4	2.65	2.65	2.65	0	0	DE
12	2.65	2.65	2.65	12697	2.65	DE
26	2.65	2.65	2.65	8274	2.65	DE
52	2.65	2.65	2.65	4229	2.65	DE
156	2.65	2.65	2.65	2572	2.65	DE
260	2.65	2.65	2.65	2122	2.65	DE

0QDU - Frequently Asked Questions (FAQ)

What is the current Abliva Ab share price?

The current share price of Abliva Ab is SEK 2.65

How many Abliva Ab shares are in issue?

Abliva Ab has 1,056,299,000 shares in issue

What is the market cap of Abliva Ab?

The market capitalisation of Abliva Ab is SEK 2.8B

What is the 1 year trading range for Abliva Ab share price?

Abliva Ab has traded in the range of SEK 2.65 to SEK 2.65 during the past year

What is the PE ratio of Abliva Ab?

The price to earnings ratio of Abliva Ab is -29.31

What is the cash to sales ratio of Abliva Ab?

The cash to sales ratio of Abliva Ab is 26.5k

What is the reporting currency for Abliva Ab?

Abliva Ab reports financial results in SEK

What is the latest annual turnover for Abliva Ab?

The latest annual turnover of Abliva Ab is SEK 137k

What is the latest annual profit for Abliva Ab?

The latest annual profit of Abliva Ab is SEK -95.51M

What is the registered address of Abliva Ab?

The registered address for Abliva Ab is MEDICON VILLAGE, SCHEELEVAGEN 2, LUND, 223 81

What is the Abliva Ab website address?

The website address for Abliva Ab is www.abliva.com

Which industry sector does Abliva Ab operate in?

Abliva Ab operates in the MED, DENTAL, HOSP EQ-WHSL sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
GCMGcm Resources Plc	2.80p (47.37%)	7.51M
SNGSynairgen Plc	1.26p (40.00%)	2.09M
THRUThruvision Group Plc	0.90p (38.46%)	10.74M
NARFNarf Industries Plc	0.45p (38.46%)	18.45M
XTRXtract Resources Plc	0.90p (28.57%)	12.34M
ENETEthernity Networks Ltd	0.0425p (-32.00%)	250.35M
BIOMBiome Technologies Plc	1.00p (-20.00%)	863.66k
PYXPyx Resources Limited	1.60p (-17.74%)	415.36k
ADMEAdm Energy Plc	0.25p (-16.67%)	1.04M
SYMESupply@me Capital Plc	0.003p (-14.29%)	188.86M
PREMPremier African Minerals Limited	0.01175p (12.98%)	1.45B
CPAICapai Plc	0.135p (14.89%)	1B
UKOGUk Oil & Gas Plc	0.011p (4.76%)	350.88M
ENETEthernity Networks Ltd	0.0425p (-32.00%)	250.35M
EMEEmpyrean Energy Plc	0.11p (-10.20%)	191.13M